Skip to main content
. 2019 Aug 8;5(10):1448–1455. doi: 10.1001/jamaoncol.2019.1847

Figure 1. CONSORT Diagram.

Figure 1.

aPrescreening data were not collected, and patients were registered only once they were determined to be eligible. Thus, only data for the registered and randomized patients were available.

bPatient received erlotinib plus bevacizumab rather than single-agent erlotinib.